Neurobiology of alcohol abuse

https://doi.org/10.1016/0165-6147(92)90065-EGet rights and content

Abstract

Excessive consumption of beveruge alcohol (ethanol) is a major health concern worldwide. Understanding the mechanisms by which ethanol affects neural functioning, after both acute and chronic exposure, has become a major goal in the study of alcoholism. With such an understanding, we should be able to institute more effective treatments and preventative measures for alcohol abuse problems. Recent studies have found, contrary to earlier assumptions, that ethanol has selective, dose-dependent effects on various neurotransmitter systems within the CNS. These effects are observed at all levels of analysis, from molecular to behavioral. This review by Herman Samson and Adron Harris covers these recent findings, with the intent of generating questions that will focus further research efforts.

References (36)

  • R.L. Lipnick

    Trends Pharmacol. Sci.

    (1986)
  • S.A. Forman et al.

    Trends Pharmacol. Sci.

    (1989)
  • R.A. Gonzales et al.

    Trends Pharmacol. Sci.

    (1991)
  • K.A. Wafford

    Neuron

    (1991)
  • H.H. Samson et al.

    Alcohol

    (1990)
  • H.H. Samson et al.

    Drug Alcohol Depend.

    (1990)
  • H.H. Samson et al.

    Pharmacol. Biochem. Behav.

    (1974)
  • M.B. Waller et al.

    Pharmacol. Biochem. Behav.

    (1983)
  • R.A. Deitrich et al.

    Pharmacol. Rev.

    (1989)
  • K.J. Buck et al.

    Alcohol. Clin. Exp. Res.

    (1991)
  • A.M. Allan et al.
  • P. Montpied

    Mol. Pharmacol.

    (1991)
  • K.J. Buck et al.

    Mol. Neuropharmacol.

    (1991)
  • T.J. Phillips et al.
  • B.H. Hwang et al.

    Alcohol. Clin. Exp. Res.

    (1990)
  • P.L. Hoffman et al.

    FASEB J.

    (1990)
  • E.P. Noble et al.

    Arch. Gen. Psychiatry

    (1991)
  • Cited by (259)

    • Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1

      2020, Brain Research
      Citation Excerpt :

      Rats treated with this DPP-IV inhibitor, sitagliptin, show a delay in tolerance to alcohol’s anxiolytic properties and display a reduced anxiety following alcohol withdrawal (Sharma et al., 2014b). Since anxiety during alcohol withdrawal contributes to relapse to alcohol drinking (Roelofs, 1985; Samson and Harris, 1992), these data indicate that higher endogenous levels of GLP-1 may reduce the probability of relapse drinking. Weather this attenuation in withdrawal symptoms correlates to an elevation of central and/or peripheral GLP-1 levels needs to be evaluated.

    View all citing articles on Scopus
    View full text